Prilosec OTC Forced Name Change Rejected As FDA Clears Pending Petitions
This article was originally published in The Tan Sheet
Executive Summary
A lack of data supporting consumer confusion claims between nonprescription Prilosec and the eponymous Rx version is cited by FDA in a letter denying a citizen petition. The petitioner sought an agency-mandated name change